RSCM
CAI

Rock Springs Capital Management’s Caris Life Sciences CAI Stock Holding History

Rock Springs Capital Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69M Sell
487,500
-75,500
-13% -$1.35M 0.42% 60
2026
Q1 		$10.1M Sell
563,000
-124,500
-18% -$2.72M 0.59% 47
2025
Q4 		$18.5M Sell
687,500
-106,151
-13% -$2.99M 0.95% 34
2025
Q3 		$24M Hold
793,651
– – 1.4% 27
2025
Q2 		$21.2M Buy
+793,651
New +$21.4M 1.32% 29

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rock Springs Capital Management's CAI Position: Q2 2026 in Review

Rock Springs Capital Management reduced its Caris Life Sciences (CAI) stake by 13% in Q2 2026, selling an estimated $1.35M and leaving 487,500 shares worth $8.69M. The position accounts for 0.42% of the portfolio, ranked #60.

Rock Springs Capital Management first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $24M in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Rock Springs Capital Management held 487,500 shares of Caris Life Sciences worth $8.69M as of Q2 2026.
  • Rock Springs Capital Management sold 75,500 Caris Life Sciences shares in Q2 2026, an estimated $1.35M.
  • Caris Life Sciences made up 0.42% of Rock Springs Capital Management's portfolio in Q2 2026, its #60 holding.
  • Rock Springs Capital Management first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Rock Springs Capital Management's Caris Life Sciences position peaked at $24M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.